Bernhardt, Denise http://orcid.org/0000-0001-5231-9097
König, Laila
Grosu, Anca-L.
Rieken, Stefan
Krieg, Sandro M.
Wick, Wolfgang
Wiestler, Benedikt
Schmidt-Graf, Friederike
Sahm, Felix
Gempt, Jens
Meyer, Bernhard
Krause, Bernd J.
Petersen, Cordula
Fietkau, Rainer
Thomas, Michael
Giordano, Frank
Wittig-Sauerwein, Andrea
Debus, Jürgen
Tabatabai, Ghazaleh
Hau, Peter
Steinbach, Joachim
Combs, Stephanie E.
,
Funding for this research was provided by:
Klinikum rechts der Isar der Technischen Universität München
Article History
Received: 11 June 2022
Accepted: 15 June 2022
First Online: 29 August 2022
Declarations
:
: D. Bernhardt reports personal fees and honoraria from Accuray Inc., AstraZeneca, and Novocure GmbH outside the submitted work. DB’s spouse is employed at Gilead Science. L. König reports grants from Ruprecht-Karls Universität Heidelberg, and personal fees from Accuray Inc. and Novocure GmbH outside the submitted work. J. Debus: institution received research grants from Merck Serono, institution received consultation honoraria from Merck serono, JD received travel reimbursement from Merck Serono, institution received research grants from Siemens Healthineers and Accuray. S. Rieken is consultant for Brainlab AG (Munich, Germany) and Ulrich Medical (Ulm, Germany). S.K. received honoraria from Nexstim Plc (Helsinki, Finland), Spineart Deutschland GmbH (Frankfurt, Germany), Medtronic (Meerbusch, Germany), and Carl Zeiss Meditec (Oberkochen, Germany). M. Thomas reports personal fees, honoraria for advisory boards, and research funding from AstraZeneca, Beigene, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene, Chugai, Daiichi Sankyo, GlaxoSmithKline, Janssen Oncology, Lilly, Merck, MSD, Novartis, Pfizer, Roche, Sanofi, and Takeda. F. Giordano reports research grants, honoraria, and travel expenses from Carl Zeiss Meditec AG and NOXXON Pharma AG, personal fees from MVZ Venusberg GmbH, and consulting/speaker honoraria from Bristol Myers Squibb, Medac GmbH, Merck Sharp & Dohme, Elsevier, AstraZeneca, and Guerbet SA. A.-L. Grosu, S.M. Krieg, W. Wick, B. Wiestler, F. Schmidt-Graf, F. Sahm, J. Gempt, B. Meyer, B.J. Krause, C. Petersen, R. Fietkau, A. Wittig-Sauerwein, G. Tabatabai, P. Hau, J. Steinbach, S.E. Combs, and the Expert Panel of the German Society of Radiation Oncology (DEGRO) declare that they have no competing interests.
: Ethics approval was not necessary for the comprehensive review article. All co-authors have agreed to participate<b><i>. </i></b><i>Consent for publication</i>: All co-authors have approved the final manuscript.